Lancet Diabetes Endocrinol 3(5):367381 van Bommel EJM, Muskiet MHA, Tonneijck L, Kramer MHH, Nieuwdorp M, van Raalte DH (2017) SGLT2 inhibition in the diabetic kidneyfrom mechanisms to clinical outcome
In clinical trials, participants are escalated through increasing doses over weeks under medical monitoring
Reconstituting in bacteriostatic water (pH approximately 4.5 to 7.0) is preferable to alkaline solutions, which can accelerate peptide hydrolysis and copper deposition
Many of the studies in the review were done on animals, and the ones that involved humans were small
Poorly controlled hyperthyroidism poses greater risk
The Psychological and Spiritual Components of Healing Dr